Sastasundar Ventures has informed that the Company has signed a Share Purchase Agreement (the Agreement) today i.e. 5th March, 2019 with Sastasundar Healthbuddy Limited, a subsidiary Company (the Acquirer), to sell and transfer the entire stake held by the Company in Genu Path Labs, a wholly owned subsidiary company. The details as required under regulation 30 of the SEBI Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexure -A to this letter.
The above information is a part of company’s filings submitted to BSE.
